Awardee OrganizationBOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
Description
Abstract Text
Project summary
Although fluorescence microscopy has matured into a prevalent imaging method for biomedical researchers,
fluorescence spectroscopy exhibits several fundamental limitations: (1) lack of composition information; (2)
inability of imaging small biomolecules; (3) color barrier of multiplexing imaging; (4) lack of chemical sensitivity.
To this end, the advent of stimulated Raman scattering (SRS) microscopy have revolutionized chemical
imaging. Most importantly, recent developments have proven that SRS microscopy can be complimentary to
fluorescence in addressing the above-mentioned limitations: (1) revealing chemical compositions by targeting
their endogenous chemical bonds; (2) employing a set of bioorthogonal vibrational tags (such as C≡C, C≡N,
carbon-deuterium C-D and 13C isotope) to image small biomolecules; (3) presenting an appealing strategy to
surpass the “color barrier” when coupled with super-multiplexed probes; (4) containing information about
structure and dynamics of the target molecule, as well as its interaction with environment.
Although SRS has the promise to emerge as the next major modality in biophotonics, its utility has been
limited in the following two major aspects. First, the sensitivity of SRS microscopy has reached an impasse.
Currently, the detection limit cannot image many important small analytes and chemical drugs inside cells, which
are below the concentration of 100 micromolar. Second, although SRS is compatible with live cell biology, the
application of SRS inside live cells is significantly under-explored, largely due to that the available probes for
SRS imaging are seriously lagging behind. As such, many advanced applications of chemical imaging have not
been realized.
We propose to develop the next-generation, ultrasensitive SRS microscopy by integrating innovations from
imaging instrumentation, probe chemistry and data science. We will employ a new laser source to push SRS
microscopy to the nanomolar range for small fundamental chemical bonds. Meanwhile, we will systematically
develop a library of responsive Raman sensors that can enter live cells and monitor important analytes there.
Moreover, we will deploy newly developed machine learning algorithms to further assist live-cell imaging. When
fully optimized, this will bring SRS microscopy to the ultimate sensitivity (comparable to that of fluorescence
microscopy), and fully open the application in live cell biology.
Public Health Relevance Statement
Project narrative
We will develop the next-generation, ultrasensitive stimulated Raman scattering (SRS) microscopy by integrating
innovations from imaging instrumentation, probe chemistry and data science. This research will bring SRS
microscopy to the ultimate sensitivity (comparable to that of fluorescence microscopy), and fully open the
application in live cell biology.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
049435266
UEI
THL6A6JLE1S7
Project Start Date
01-January-2024
Project End Date
21-December-2027
Budget Start Date
01-January-2025
Budget End Date
31-December-2025
Project Funding Information for 2025
Total Funding
$543,462
Direct Costs
$455,804
Indirect Costs
$87,658
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Biomedical Imaging and Bioengineering
$543,462
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB035429-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB035429-02
Patents
No Patents information available for 5R01EB035429-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB035429-02
Clinical Studies
No Clinical Studies information available for 5R01EB035429-02
News and More
Related News Releases
No news release information available for 5R01EB035429-02
History
No Historical information available for 5R01EB035429-02
Similar Projects
No Similar Projects information available for 5R01EB035429-02